Recent NERV News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 02:00:15 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/07/2026 05:15:18 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/06/2026 09:52:46 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/31/2025 09:30:23 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/29/2025 01:29:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/23/2025 09:52:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 09:15:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 09:15:17 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/23/2025 09:05:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2025 09:05:13 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/24/2025 09:05:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 01:40:06 PM
- Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors • GlobeNewswire Inc. • 11/19/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:49:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:47:22 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/14/2025 09:36:10 PM
- Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates • GlobeNewswire Inc. • 11/05/2025 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2025 12:00:46 PM
- Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation • GlobeNewswire Inc. • 10/21/2025 12:00:00 PM
- Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results • GlobeNewswire Inc. • 08/14/2025 08:35:00 PM
- Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates • GlobeNewswire Inc. • 05/13/2025 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 11:00:34 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/21/2025 08:55:27 PM
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing • HYDI • Feb 10, 2026 10:58 AM
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • MWAI • Feb 10, 2026 8:45 AM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM
Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM
